The murine mammary carcinoma 59-2-HI, which expresses high estrogen receptor alpha (ER) and PR levels, regresses completely when a 6 mg mifepristone pellet is implanted subcutaneously (Vanzulli et al. 2002). Here, ESR1 is linked to breast carcinoma.